Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with or without ursodeoxycholic acid for duodenal adenomas in familial adenomatous polyposis
NL-OMON32335Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Colonic Adenomatous Polyposis and Duodenal adenoma (DA) comparing Celecoxib + placebo with Celecoxib + ursodeoxycholic acid (2 arms). Primary endpoints: Number and size of duodenal adenomas and Duodenal mucosal cell proliferation and apoptosis. Started Feb 2009; status: active, not recruiting.
02
Drugs
celecoxibursodeoxycholic acid
03
Conditions
Colonic Adenomatous PolyposisDuodenal adenoma (DA)
Beyond the preview
Go deeper on NL-OMON32335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32335.